Global Parkinson's Disease (PD) Drugs Market Research Report 2022

Global Parkinson's Disease (PD) Drugs Market Research Report 2022

Table of Contents
1 Parkinson's Disease (PD) Drugs Market Overview
1.1 Product Overview and Scope of Parkinson's Disease (PD) Drugs
1.2 Parkinson's Disease (PD) Drugs Segment by Type
1.2.1 Global Parkinson's Disease (PD) Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Dopamine Agonist
1.2.3 Monoamine Oxidase Inhibitors
1.2.4 Acetylcholinesterase Inhibitors
1.2.5 Glutamate Inhibitors
1.3 Parkinson's Disease (PD) Drugs Segment by Application
1.3.1 Global Parkinson's Disease (PD) Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Family
1.4 Global Parkinson's Disease (PD) Drugs Market Size Estimates and Forecasts
1.4.1 Global Parkinson's Disease (PD) Drugs Revenue 2017-2028
1.4.2 Global Parkinson's Disease (PD) Drugs Sales 2017-2028
1.4.3 Parkinson's Disease (PD) Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Parkinson's Disease (PD) Drugs Market Competition by Manufacturers
2.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Parkinson's Disease (PD) Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Parkinson's Disease (PD) Drugs Manufacturing Sites, Area Served, Product Type
2.5 Parkinson's Disease (PD) Drugs Market Competitive Situation and Trends
2.5.1 Parkinson's Disease (PD) Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Parkinson's Disease (PD) Drugs Players Market Share by Revenue
2.5.3 Global Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Parkinson's Disease (PD) Drugs Retrospective Market Scenario by Region
3.1 Global Parkinson's Disease (PD) Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Parkinson's Disease (PD) Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
3.3.1 North America Parkinson's Disease (PD) Drugs Sales by Country
3.3.2 North America Parkinson's Disease (PD) Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
3.4.1 Europe Parkinson's Disease (PD) Drugs Sales by Country
3.4.2 Europe Parkinson's Disease (PD) Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Parkinson's Disease (PD) Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region
3.5.2 Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
3.6.1 Latin America Parkinson's Disease (PD) Drugs Sales by Country
3.6.2 Latin America Parkinson's Disease (PD) Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country
3.7.2 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Parkinson's Disease (PD) Drugs Historic Market Analysis by Type
4.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2022)
4.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Parkinson's Disease (PD) Drugs Price by Type (2017-2022)
5 Global Parkinson's Disease (PD) Drugs Historic Market Analysis by Application
5.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2022)
5.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Parkinson's Disease (PD) Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Novartis Parkinson's Disease (PD) Drugs Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Teva Pharmaceutical Industries
6.4.1 Teva Pharmaceutical Industries Corporation Information
6.4.2 Teva Pharmaceutical Industries Description and Business Overview
6.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Portfolio
6.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Corporation Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 AbbVie Parkinson's Disease (PD) Drugs Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 Abital Pharma
6.6.1 Abital Pharma Corporation Information
6.6.2 Abital Pharma Description and Business Overview
6.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Product Portfolio
6.6.5 Abital Pharma Recent Developments/Updates
6.7 Addex Therapeutics
6.6.1 Addex Therapeutics Corporation Information
6.6.2 Addex Therapeutics Description and Business Overview
6.6.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Portfolio
6.7.5 Addex Therapeutics Recent Developments/Updates
6.8 Biogen
6.8.1 Biogen Corporation Information
6.8.2 Biogen Description and Business Overview
6.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Biogen Parkinson's Disease (PD) Drugs Product Portfolio
6.8.5 Biogen Recent Developments/Updates
6.9 Eisai
6.9.1 Eisai Corporation Information
6.9.2 Eisai Description and Business Overview
6.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Eisai Parkinson's Disease (PD) Drugs Product Portfolio
6.9.5 Eisai Recent Developments/Updates
6.10 Eli Lilly
6.10.1 Eli Lilly Corporation Information
6.10.2 Eli Lilly Description and Business Overview
6.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Product Portfolio
6.10.5 Eli Lilly Recent Developments/Updates
6.11 F. Hoffmann-La Roche
6.11.1 F. Hoffmann-La Roche Corporation Information
6.11.2 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Description and Business Overview
6.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Portfolio
6.11.5 F. Hoffmann-La Roche Recent Developments/Updates
6.12 H. Lundbeck
6.12.1 H. Lundbeck Corporation Information
6.12.2 H. Lundbeck Parkinson's Disease (PD) Drugs Description and Business Overview
6.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 H. Lundbeck Parkinson's Disease (PD) Drugs Product Portfolio
6.12.5 H. Lundbeck Recent Developments/Updates
6.13 Impax Laboratories
6.13.1 Impax Laboratories Corporation Information
6.13.2 Impax Laboratories Parkinson's Disease (PD) Drugs Description and Business Overview
6.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Impax Laboratories Parkinson's Disease (PD) Drugs Product Portfolio
6.13.5 Impax Laboratories Recent Developments/Updates
6.14 Kyowa Hakko Kirin
6.14.1 Kyowa Hakko Kirin Corporation Information
6.14.2 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Description and Business Overview
6.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Portfolio
6.14.5 Kyowa Hakko Kirin Recent Developments/Updates
6.15 Otsuka Pharmaceutical
6.15.1 Otsuka Pharmaceutical Corporation Information
6.15.2 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Description and Business Overview
6.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Portfolio
6.15.5 Otsuka Pharmaceutical Recent Developments/Updates
6.16 Pfizer
6.16.1 Pfizer Corporation Information
6.16.2 Pfizer Parkinson's Disease (PD) Drugs Description and Business Overview
6.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Pfizer Parkinson's Disease (PD) Drugs Product Portfolio
6.16.5 Pfizer Recent Developments/Updates
7 Parkinson's Disease (PD) Drugs Manufacturing Cost Analysis
7.1 Parkinson's Disease (PD) Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs
7.4 Parkinson's Disease (PD) Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Parkinson's Disease (PD) Drugs Distributors List
8.3 Parkinson's Disease (PD) Drugs Customers
9 Parkinson's Disease (PD) Drugs Market Dynamics
9.1 Parkinson's Disease (PD) Drugs Industry Trends
9.2 Parkinson's Disease (PD) Drugs Market Drivers
9.3 Parkinson's Disease (PD) Drugs Market Challenges
9.4 Parkinson's Disease (PD) Drugs Market Restraints
10 Global Market Forecast
10.1 Parkinson's Disease (PD) Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Parkinson's Disease (PD) Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Parkinson's Disease (PD) Drugs by Type (2023-2028)
10.2 Parkinson's Disease (PD) Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Parkinson's Disease (PD) Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Parkinson's Disease (PD) Drugs by Application (2023-2028)
10.3 Parkinson's Disease (PD) Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Parkinson's Disease (PD) Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Parkinson's Disease (PD) Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Parkinson's Disease (PD) Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
Table 2. Global Parkinson's Disease (PD) Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
Table 3. Global Parkinson's Disease (PD) Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Parkinson's Disease (PD) Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) of Key Manufacturers (2017-2022)
Table 6. Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Parkinson's Disease (PD) Drugs Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Parkinson's Disease (PD) Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Parkinson's Disease (PD) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Parkinson's Disease (PD) Drugs Sales by Region (2017-2022) & (K Pcs)
Table 16. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Parkinson's Disease (PD) Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Parkinson's Disease (PD) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 20. North America Parkinson's Disease (PD) Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Parkinson's Disease (PD) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 24. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2017-2022) & (K Pcs)
Table 28. Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 32. Latin America Parkinson's Disease (PD) Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 36. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 40. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Parkinson's Disease (PD) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Parkinson's Disease (PD) Drugs Revenue Share by Type (2017-2022)
Table 43. Global Parkinson's Disease (PD) Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 44. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Application (2017-2022)
Table 45. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2022)
Table 46. Global Parkinson's Disease (PD) Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Parkinson's Disease (PD) Drugs Revenue Share by Application (2017-2022)
Table 48. Global Parkinson's Disease (PD) Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 49. Boehringer Ingelheim Corporation Information
Table 50. Boehringer Ingelheim Description and Business Overview
Table 51. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 52. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product
Table 53. Boehringer Ingelheim Recent Developments/Updates
Table 54. GlaxoSmithKline Corporation Information
Table 55. GlaxoSmithKline Description and Business Overview
Table 56. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 57. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product
Table 58. GlaxoSmithKline Recent Developments/Updates
Table 59. Novartis Corporation Information
Table 60. Novartis Description and Business Overview
Table 61. Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 62. Novartis Parkinson's Disease (PD) Drugs Product
Table 63. Novartis Recent Developments/Updates
Table 64. Teva Pharmaceutical Industries Corporation Information
Table 65. Teva Pharmaceutical Industries Description and Business Overview
Table 66. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 67. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product
Table 68. Teva Pharmaceutical Industries Recent Developments/Updates
Table 69. AbbVie Corporation Information
Table 70. AbbVie Description and Business Overview
Table 71. AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 72. AbbVie Parkinson's Disease (PD) Drugs Product
Table 73. AbbVie Recent Developments/Updates
Table 74. Abital Pharma Corporation Information
Table 75. Abital Pharma Description and Business Overview
Table 76. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 77. Abital Pharma Parkinson's Disease (PD) Drugs Product
Table 78. Abital Pharma Recent Developments/Updates
Table 79. Addex Therapeutics Corporation Information
Table 80. Addex Therapeutics Description and Business Overview
Table 81. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 82. Addex Therapeutics Parkinson's Disease (PD) Drugs Product
Table 83. Addex Therapeutics Recent Developments/Updates
Table 84. Biogen Corporation Information
Table 85. Biogen Description and Business Overview
Table 86. Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 87. Biogen Parkinson's Disease (PD) Drugs Product
Table 88. Biogen Recent Developments/Updates
Table 89. Eisai Corporation Information
Table 90. Eisai Description and Business Overview
Table 91. Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 92. Eisai Parkinson's Disease (PD) Drugs Product
Table 93. Eisai Recent Developments/Updates
Table 94. Eli Lilly Corporation Information
Table 95. Eli Lilly Description and Business Overview
Table 96. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 97. Eli Lilly Parkinson's Disease (PD) Drugs Product
Table 98. Eli Lilly Recent Developments/Updates
Table 99. F. Hoffmann-La Roche Corporation Information
Table 100. F. Hoffmann-La Roche Description and Business Overview
Table 101. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 102. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product
Table 103. F. Hoffmann-La Roche Recent Developments/Updates
Table 104. H. Lundbeck Corporation Information
Table 105. H. Lundbeck Description and Business Overview
Table 106. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 107. H. Lundbeck Parkinson's Disease (PD) Drugs Product
Table 108. H. Lundbeck Recent Developments/Updates
Table 109. Impax Laboratories Corporation Information
Table 110. Impax Laboratories Description and Business Overview
Table 111. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 112. Impax Laboratories Parkinson's Disease (PD) Drugs Product
Table 113. Impax Laboratories Recent Developments/Updates
Table 114. Kyowa Hakko Kirin Corporation Information
Table 115. Kyowa Hakko Kirin Description and Business Overview
Table 116. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 117. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product
Table 118. Kyowa Hakko Kirin Recent Developments/Updates
Table 119. Otsuka Pharmaceutical Corporation Information
Table 120. Otsuka Pharmaceutical Description and Business Overview
Table 121. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 122. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product
Table 123. Otsuka Pharmaceutical Recent Developments/Updates
Table 124. Pfizer Corporation Information
Table 125. Pfizer Description and Business Overview
Table 126. Pfizer Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 127. Pfizer Parkinson's Disease (PD) Drugs Product
Table 128. Pfizer Recent Developments/Updates
Table 129. Production Base and Market Concentration Rate of Raw Material
Table 130. Key Suppliers of Raw Materials
Table 131. Parkinson's Disease (PD) Drugs Distributors List
Table 132. Parkinson's Disease (PD) Drugs Customers List
Table 133. Parkinson's Disease (PD) Drugs Market Trends
Table 134. Parkinson's Disease (PD) Drugs Market Drivers
Table 135. Parkinson's Disease (PD) Drugs Market Challenges
Table 136. Parkinson's Disease (PD) Drugs Market Restraints
Table 137. Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
Table 138. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Type (2023-2028)
Table 139. Global Parkinson's Disease (PD) Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 140. Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 141. Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2023-2028) & (K Pcs)
Table 142. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Application (2023-2028)
Table 143. Global Parkinson's Disease (PD) Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 144. Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 145. Global Parkinson's Disease (PD) Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 146. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Region (2023-2028)
Table 147. Global Parkinson's Disease (PD) Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 148. Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Parkinson's Disease (PD) Drugs
Figure 2. Global Parkinson's Disease (PD) Drugs Market Share by Type in 2021 & 2028
Figure 3. Dopamine Agonist Product Picture
Figure 4. Monoamine Oxidase Inhibitors Product Picture
Figure 5. Acetylcholinesterase Inhibitors Product Picture
Figure 6. Glutamate Inhibitors Product Picture
Figure 7. Global Parkinson's Disease (PD) Drugs Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Family
Figure 10. Global Parkinson's Disease (PD) Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Parkinson's Disease (PD) Drugs Market Size (2017-2028) & (US$ Million)
Figure 12. Global Parkinson's Disease (PD) Drugs Sales (2017-2028) & (K Pcs)
Figure 13. Parkinson's Disease (PD) Drugs Sales Share by Manufacturers in 2021
Figure 14. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Parkinson's Disease (PD) Drugs Players: Market Share by Revenue in 2021
Figure 16. Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2017-2022)
Figure 18. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region in 2021
Figure 19. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2017-2022)
Figure 20. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region in 2021
Figure 21. U.S. Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Taiwan Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Philippines Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Vietnam Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Parkinson's Disease (PD) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Parkinson's Disease (PD) Drugs by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Parkinson's Disease (PD) Drugs
Figure 47. Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs
Figure 48. Parkinson's Disease (PD) Drugs Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs